Pharmacy

Laura and John Arnold are among the early billionaire investors in Civica Rx, the hospital-owned nonprofit generic drug company.

In an effort to fight the Trump administration's plan to overhaul the prescription rebate system, a coalition of pharmacy benefit managers has launched a public relations campaign touting the value PBMs bring to the pharmaceutical industry.

Although there has been a jump in FDA generic drug approvals in the last two years, nearly half of the medications are not sold in the U.S., according to a Kaiser Health News report.

Consumers want Amazon to offer more healthcare-related services and products, including telehealth and prescription drugs, a new survey from Investing.com suggests.

Individual generic drugmakers, including Mylan and Teva, were urged to step up their lobbying efforts at the leading generic drug trade group's meeting, according to Bloomberg Law.

Walgreens will pay about $2 million to resolve two lawsuits alleging it overcharged the Massachusetts Medicaid program and falsified information on some of the reimbursement claims, according to The Berkshire Eagle.

The Senate Finance Committee on Feb. 4 invited seven CEOs from major drug companies to testify at a hearing about high prescription drug costs later this month. So far, four of the companies have agreed to send their executives to…

GlaxoSmithKline and Merck have partnered to develop and commercialize a cancer immunotherapy treatment in a deal that could be valued at $4.2 billion, Bloomberg reports.

Hedge fund Appaloosa LP is placing more pressure on Allergan to separate the roles of chairman and CEO in an effort to address the drugmaker's underperformance.

ProvideGx, a company established by Premier in January to address generic drug shortages, will start with manufacturing a blood pressure medication that has been hard to obtain.